74 related articles for article (PubMed ID: 18673240)
1. Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views.
Kim MJ; Huang Y; Park JI
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291655
[TBL] [Abstract][Full Text] [Related]
2. Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP.
Xie Y; Wang F; Yu J; Zhang J; Liu Y; Li M; Qi J
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617573
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Notch signaling pathway in cancer therapeutics.
Guo H; Lu Y; Wang J; Liu X; Keller ET; Liu Q; Zhou Q; Zhang J
Thorac Cancer; 2014 Nov; 5(6):473-86. PubMed ID: 26767041
[TBL] [Abstract][Full Text] [Related]
4. Nrdp1 inhibits metastasis of colorectal cancer cells by EGFR signaling-dependent MMP7 modulation.
Jiang Y; Sun S; Liu G; Yan B; Niu J
Tumour Biol; 2015 Feb; 36(2):1129-33. PubMed ID: 25330950
[TBL] [Abstract][Full Text] [Related]
5. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
[TBL] [Abstract][Full Text] [Related]
6. Nrdp1 inhibits growth of colorectal cancer cells by nuclear retention of p27.
Lu H; Li H; Mao D; Zhu Z; Sun H
Tumour Biol; 2014 Sep; 35(9):8639-43. PubMed ID: 24867101
[TBL] [Abstract][Full Text] [Related]
7. Natural history of hepatic metastases from colorectal cancer--pathobiological pathways with clinical significance.
Paschos KA; Majeed AW; Bird NC
World J Gastroenterol; 2014 Apr; 20(14):3719-37. PubMed ID: 24744570
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
[TBL] [Abstract][Full Text] [Related]
9. Identification of pathway deregulation--gene expression based analysis of consistent signal transduction.
Mieczkowski J; Swiatek-Machado K; Kaminska B
PLoS One; 2012; 7(7):e41541. PubMed ID: 22848524
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
Masuda M; Sawa M; Yamada T
Pharmacol Ther; 2015 Dec; 156():1-9. PubMed ID: 26542362
[TBL] [Abstract][Full Text] [Related]
12. Targeting the most upstream site of Wnt signaling pathway provides a strategic advantage for therapy in colorectal cancer.
Qi J; Zhu YQ
Curr Drug Targets; 2008 Jul; 9(7):548-57. PubMed ID: 18673240
[TBL] [Abstract][Full Text] [Related]
13. Wnt signaling as a therapeutic target for cancer.
Herbst A; Kolligs FT
Methods Mol Biol; 2007; 361():63-91. PubMed ID: 17172707
[TBL] [Abstract][Full Text] [Related]
14. Wnt/Frizzled signaling in hepatocellular carcinoma.
Lee HC; Kim M; Wands JR
Front Biosci; 2006 May; 11():1901-15. PubMed ID: 16368566
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers.
Ying Y; Tao Q
Epigenetics; 2009 Jul; 4(5):307-12. PubMed ID: 19633433
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
